Page last updated: 2024-09-04

interleukin 1beta (193-195) and Inflammatory Bowel Diseases

interleukin 1beta (193-195) has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bednarz-Misa, I; Kapturkiewicz, B; Krzystek-Korpacka, M; Neubauer, K; Zacharska, E1

Other Studies

1 other study(ies) available for interleukin 1beta (193-195) and Inflammatory Bowel Diseases

ArticleYear
Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2020, Volume: 29, Issue:5

    Topics: Actins; Angiogenesis Inducing Agents; beta 2-Microglobulin; Biomarkers, Tumor; Chemokine CCL4; Colorectal Neoplasms; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Humans; Inflammatory Bowel Diseases; Interleukin-1beta; Peptide Fragments; Real-Time Polymerase Chain Reaction; Reference Standards

2020